(Q46332461)

21 December 2017

title

Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles (English)

1 reference

21 December 2017

author name string

Salvatore Oddo

1

1 reference

21 December 2017

Vitaly Vasilevko

2

1 reference

21 December 2017

Antonella Caccamo

3

1 reference

21 December 2017

Masashi Kitazawa

4

1 reference

21 December 2017

David H Cribbs

5

1 reference

21 December 2017

Frank M LaFerla

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

20 October 2006

1 reference

21 December 2017

Journal of Biological Chemistry

published in

1 reference

21 December 2017

volume

281

1 reference

21 December 2017

issue

51

1 reference

21 December 2017

page(s)

39413-39423

1 reference

21 December 2017

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Deciphering the molecular basis of memory failure in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

The cytoskeleton in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Neuritic pathology and dementia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Tau suppression in a neurodegenerative mouse model improves memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

A dynamic relationship between intracellular and extracellular pools of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

The neurobiological basis of spontaneous alternation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Amygdala modulation of memory consolidation: interaction with other brain systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Tau and axonopathy in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

On the structure of microtubules, tau, and paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

CSF-tau, CSF-A�1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer?s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608485200

21 January 2018

Identifiers

DOI

10.1074/JBC.M608485200

1 reference

21 December 2017

1 reference

21 December 2017